- Home
- OCCI vs ASRT Comparison
OCCI vs ASRT Comparison
Compare OCCI & ASRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OCCI
- ASRT
- Stock Information
- Founded
- OCCI N/A
- ASRT 1995
- Country
- OCCI United States
- ASRT United States
- Employees
- OCCI N/A
- ASRT N/A
- Industry
- OCCI Trusts Except Educational Religious and Charitable
- ASRT Biotechnology: Pharmaceutical Preparations
- Sector
- OCCI Finance
- ASRT Health Care
- Exchange
- OCCI Nasdaq
- ASRT Nasdaq
- Market Cap
- OCCI 123.6M
- ASRT 105.8M
- IPO Year
- OCCI N/A
- ASRT 1997
- Fundamental
- Price
- OCCI $7.40
- ASRT $1.13
- Analyst Decision
- OCCI
- ASRT Strong Buy
- Analyst Count
- OCCI 0
- ASRT 5
- Target Price
- OCCI N/A
- ASRT $3.35
- AVG Volume (30 Days)
- OCCI 115.8K
- ASRT 415.7K
- Earning Date
- OCCI 12-11-2023
- ASRT 11-06-2024
- Dividend Yield
- OCCI 24.32%
- ASRT N/A
- EPS Growth
- OCCI N/A
- ASRT N/A
- EPS
- OCCI N/A
- ASRT N/A
- Revenue
- OCCI N/A
- ASRT $132,186,000.00
- Revenue This Year
- OCCI N/A
- ASRT N/A
- Revenue Next Year
- OCCI $10.19
- ASRT $4.68
- P/E Ratio
- OCCI N/A
- ASRT N/A
- Revenue Growth
- OCCI N/A
- ASRT N/A
- 52 Week Low
- OCCI $5.47
- ASRT $0.73
- 52 Week High
- OCCI $10.15
- ASRT $2.53
- Technical
- Relative Strength Index (RSI)
- OCCI 46.37
- ASRT 44.88
- Support Level
- OCCI $7.41
- ASRT $1.06
- Resistance Level
- OCCI $7.48
- ASRT $1.14
- Average True Range (ATR)
- OCCI 0.07
- ASRT 0.05
- MACD
- OCCI -0.01
- ASRT -0.00
- Stochastic Oscillator
- OCCI 28.57
- ASRT 36.84
About OCCI OFS Credit Company Inc.
OFS Credit Co Inc is a non-diversified, closed-end management investment company. Its investment objective is to generate current income, with a secondary objective to generate capital appreciation. The company invests in floating rate credit instruments and other structured credit investments, including; collateralized loan obligation (CLO) debt and subordinated (i.e., residual or equity) securities; traditional corporate credit investments, including leveraged loans and high yield bonds; opportunistic credit investments, including stressed and distressed credit situations and long/short credit investments; and other credit-related instruments.
About ASRT Assertio Holdings Inc.
Assertio Holdings Inc is a pharmaceutical company. It is engaged in providing solutions to advance patient care in the areas of neurology, orphan and specialty medicines. The company markets three FDA-approved products for various neurological conditions including Gralise, tablets for the management of postherpetic neuralgia; CAMBIA, for acute treatment of migraine attacks with or without aura in adults of age or older; and Zipsor, liquid-filled capsules for relief of mild to moderate pain.